Workflow
天际股份(002759) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥555,763,507.17, a decrease of 4.04% compared to the same period last year, and a year-to-date revenue of ¥1,451,909,506.52, down 11.83% year-on-year [2]. - The net profit attributable to shareholders for Q3 2024 was -¥60,800,466.41, representing a significant decline of 2,300.03% year-on-year, with a year-to-date net profit of -¥188,524,740.59, down 833.01% [2]. - Total operating revenue for Q3 2024 was CNY 1,451,909,506.52, a decrease of 11.8% compared to CNY 1,646,668,040.10 in the same period last year [16]. - Net profit for Q3 2024 was a loss of CNY 238,036,656.35, compared to a profit of CNY 37,861,727.22 in the same quarter last year [17]. - The total comprehensive income for Q3 2024 was -238,036,656.35 CNY, down from 37,861,727.22 CNY in Q3 2023 [18]. - The basic and diluted earnings per share for Q3 2024 were both -0.38 CNY, compared to 0.06 CNY in Q3 2023 [18]. Cash Flow and Liquidity - The company's cash flow from operating activities for the year-to-date period was -¥273,355,584.71, a decrease of 376.74% compared to the previous year [7]. - Cash flow from operating activities for Q3 2024 was -273,355,584.71 CNY, a decline from -57,339,020.07 CNY in the previous year [20]. - Cash inflow from operating activities totaled 1,382,108,107.73 CNY, down from 2,016,408,604.60 CNY in Q3 2023 [20]. - Cash outflow from operating activities was 1,655,463,692.44 CNY, compared to 2,073,747,624.67 CNY in the same period last year [20]. - The net cash flow from investing activities was -693,393,196.80 CNY, worsening from -306,592,965.06 CNY in Q3 2023 [20]. - The net cash flow from financing activities was 308,586,466.66 CNY, down from 568,178,579.73 CNY in the previous year [20]. - The company reported a net decrease in cash and cash equivalents of -657,278,481.02 CNY for Q3 2024, contrasting with an increase of 204,260,341.85 CNY in the same period last year [21]. - The company's cash and cash equivalents decreased by 49.08% to ¥977,042,044.73, primarily due to increased expenditures on fixed asset construction and share repurchase [5]. - The cash and cash equivalents at the end of Q3 2024 were 558,741,339.95 CNY, compared to 501,947,134.21 CNY at the end of Q3 2023 [21]. Assets and Liabilities - The total assets at the end of Q3 2024 were ¥7,264,137,063.32, down 6.25% from the end of the previous year [2]. - The company's total assets decreased to CNY 7,264,137,063.32 from CNY 7,748,144,972.66, reflecting a decline of approximately 6.2% [15]. - The company’s total liabilities decreased by 34.36% to ¥831,478,560.41, primarily due to the settlement of payable notes [5]. - The total liabilities decreased to CNY 2,384,108,374.72 from CNY 2,599,932,614.48, a reduction of about 8.3% [15]. - The total equity attributable to shareholders decreased to CNY 4,356,758,000.13 from CNY 4,665,429,753.95, a decline of approximately 6.6% [15]. Research and Development - Research and development expenses increased by 40.35% to ¥62,124,254.47 in Q3 2024, reflecting a rise in investment in R&D [6]. - Research and development expenses increased to CNY 62,124,254.47, up from CNY 44,263,534.54, representing a growth of 40.4% year-over-year [17]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 65,159 [8]. - The largest shareholder, Shantou Tianji Co., Ltd., holds 15.12% of shares, totaling 75,789,180 shares [9]. - As of the end of the reporting period, the company holds 9,621,887 shares in its repurchase account, accounting for 1.92% of the total share capital [9]. - The company has not disclosed any changes in the participation of major shareholders in margin trading [10]. Projects and Investments - The company has completed the construction of a 15,000-ton lithium hexafluorophosphate facility, which began trial production in August 2024 [11]. - The annual design capacity for lithium hexafluorophosphate has reached 37,000 tons [11]. - The company is currently constructing a 6,000-ton high-purity lithium fluoride project, which is progressing as planned [11]. - The first phase of the project invested by the wholly-owned subsidiary has completed the main structure and is entering the internal supporting and decoration stage [11]. Other Income and Financial Performance - The company reported a significant increase in other income by 367.63% to ¥9,185,807.16, mainly due to an increase in VAT deductions [6]. - The company’s weighted average return on equity was -1.33% for Q3 2024, a decrease of 1.40% compared to the previous year [2]. - The company's financial expenses increased to CNY 2,188,567.40, compared to a negative expense of CNY 5,008,201.54 in the previous year, indicating a shift in financial performance [17]. - The inventory level decreased to CNY 313,854,495.50 from CNY 384,760,162.68, indicating a reduction of about 18.4% [15]. - The company reported a significant increase in accounts receivable, which rose to CNY 513,830,469.32 from CNY 406,843,501.41, an increase of about 26.3% [15].